Free Trial

TruFin (TRU) Competitors

GBX 66.70 +0.20 (+0.30%)
(As of 11:37 AM ET)

TRU vs. MXCT, HUR, ACRL, TUNG, ADT, ULS, STAF, FCCN, CRL, and FA

Should you be buying TruFin stock or one of its competitors? The main competitors of TruFin include MaxCyte (MXCT), Hurricane Energy (HUR), Accrol Group (ACRL), Tungsten (TUNG), AdEPT Technology Group (ADT), ULS Technology (ULS), Staffline Group (STAF), French Connection Group (FCCN), Creightons (CRL), and FireAngel Safety Technology Group (FA). These companies are all part of the "business services" industry.

TruFin vs.

TruFin (LON:TRU) and MaxCyte (LON:MXCT) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings, community ranking and institutional ownership.

TruFin has a net margin of 6.98% compared to MaxCyte's net margin of -77.97%. TruFin's return on equity of -3.42% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
TruFin6.98% -3.42% 14.86%
MaxCyte -77.97%-15.33%-11.07%

61.6% of TruFin shares are owned by institutional investors. Comparatively, 70.5% of MaxCyte shares are owned by institutional investors. 23.1% of TruFin shares are owned by company insiders. Comparatively, 1.5% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

TruFin has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500.

TruFin has higher earnings, but lower revenue than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than TruFin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TruFin£36.48M1.94£2.49M£0.032,233.33
MaxCyte£45.44M6.17-£35.43M-£0.26-1,026.92

MaxCyte received 114 more outperform votes than TruFin when rated by MarketBeat users. However, 70.91% of users gave TruFin an outperform vote while only 68.92% of users gave MaxCyte an outperform vote.

CompanyUnderperformOutperform
TruFinOutperform Votes
39
70.91%
Underperform Votes
16
29.09%
MaxCyteOutperform Votes
153
68.92%
Underperform Votes
69
31.08%

In the previous week, MaxCyte had 1 more articles in the media than TruFin. MarketBeat recorded 1 mentions for MaxCyte and 0 mentions for TruFin. TruFin's average media sentiment score of 0.00 equaled MaxCyte'saverage media sentiment score.

Company Overall Sentiment
TruFin Neutral
MaxCyte Neutral

Summary

TruFin beats MaxCyte on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRU vs. The Competition

MetricTruFinCredit Services IndustryFinancial SectorLON Exchange
Market Cap£70.93M£237.51M£3.26B£1.39B
Dividend YieldN/A9.82%4.58%11.73%
P/E Ratio2,233.33300.72441.241,549.53
Price / Sales1.94129.963,277.41209,150.30
Price / Cash4.5312.1648.2332.93
Price / Book1.812.681.482.80
Net Income£2.49M£19.70M£396.75M£152.70M
7 Day Performance5.51%0.06%0.15%-0.55%
1 Month Performance14.73%169.08%7.05%7.05%
1 Year Performance17.54%28.70%15.54%91.75%

TruFin Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRU
TruFin
N/AGBX 66.70
+0.3%
N/A+17.0%£70.61M£36.48M2,223.3312,200
MXCT
MaxCyte
N/AGBX 266
+1.5%
N/A-22.4%£279.54M£45.44M-1,026.9280News Coverage
Gap Up
High Trading Volume
HUR
Hurricane Energy
N/AGBX 7.79
+4.8%
N/A+0.0%£155.02M£275.50M194.755,660High Trading Volume
ACRL
Accrol Group
N/AGBX 39
+0.5%
N/AN/A£124.36M£221.16M-3,900.00456
TUNG
Tungsten
N/AGBX 54.60
-0.5%
N/A+0.0%£69.09M£36.39M-19.50200News Coverage
ADT
AdEPT Technology Group
N/AGBX 200.50
flat
N/A+0.0%£50.21M£68.03M-1,179.4125,000
ULS
ULS Technology
N/AGBX 73
+4.4%
N/AN/A£47.36M£20.22M3.13100Gap Up
High Trading Volume
STAF
Staffline Group
N/AGBX 26.40
-2.8%
N/A+9.5%£35.57M£988.40M-208.462,300
FCCN
French Connection Group
N/AGBX 29.55
+0.9%
N/A+0.0%£28.55M£87.80M-3.791
CRL
Creightons
N/AGBX 34.60
flat
N/A+34.3%£23.68M£53.19M-692.0021,400
FA
FireAngel Safety Technology Group
N/AN/AN/AN/A£21.92M£53.35M-181.255,500High Trading Volume

Related Companies and Tools


This page (LON:TRU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners